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Acomputerizedmedicaldecision-making systemwasused
to monitor signs and predisposing factors of digoxin in-
toxication in patients receiving digoxin. This process
automatically reviewed the patient's data base nightly
for drug interactions, laboratory data and electrocar-
diographic findings with known associationwith digoxin
intoxication. These decisions were formated into a "di-
goxinalert report" and sent to line printers in the nurs-
ing division to be placed on the individual patients'
charts.
To assess the effect of these reports on patient man-
agement, a randomized double-blind study was under-
taken. Patients were assigned to an alert or nonalert
group. Alert reports were withheld from charts of pa-
tients in the nonalert group. A medical record review
was subsequently carried out, wherein the physician's
Although the problem of digoxin intoxicationhas been known
for many years, digoxin continues to be the fifth most
frequently prescribed drug in the United States (1). Car-
diologists and noncardiologists are frequently challenged by
the task of maintaining adequate drug levels in their patients
while avoiding the dangerous consequences of toxicity. Un-
fortunately, no definitive markers of digoxin intoxication
have been defined. Even serum digoxin level elevation lacks
adequate sensitivity and specificity to make the diagnosis.
The diagnosis of digoxin intoxication is most often made
when clinical findings lead the physician to suspect toxicity,
and discontinuation of the drug leads to abatement of
symptoms.
A number of medical conditions including pulmonary
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orders were searched to identify actions taken with pos-
sible relation to the digoxin alerts.
The computer monitored 396 patients over a 3 month
period. Ofthese, 211(53%) were randomized to the alert
group and 185 (47%) to the nonalert group. Seventy-
two percent of patients received at least one alert. The
most frequently occurring alerts included: hypoxemia,
hypokalemia, concurrent use of a beta-adrenergic block-
ing agent, renal insufficiency and ventricular arrhyth-
mia. Results from the record review demonstrated a
22% increase in physician actions for the alert group.
Specifically, patients in the alert group were 2.7 times
more likely to have a serum digoxin determination or-
dered and 2.8 times more likely to have digoxinwithheld
on the day of a digoxin alert than were patients in the
nonalert group.
disease, electrolyte imbalances, acute myocardial infarc-
tion, renal insufficiency and advanced age predispose to
digoxin intoxication and should alert the physician to the
possibility of toxicity in the patient (2-4). Although these
are common and nonspecific conditions, they should be
considered carefully in management of the patient.
Quinidine, potassium-depleting diuretic drugs, beta-ad-
renergic receptor antagonists and calcium channel blocking
agents have all been shown to interact with digoxin and
enhance its toxic potential (2,3,5,6). These drugs are used
frequently in patients with heart disease and are often given
along with digoxin. Use of these drugs concurrently with
digoxin should increase the clinician's awareness that in-
toxication may occur.
Clinical manifestations of digoxin intoxication include
fatigue, nausea, visual changes, confusion and arrhythmias.
These manifestations suggest intoxication, but are usually
not specific enough to permit the diagnosis until discontin-
uation of the drug results in their abatement (3,4,7).
Although the factors contributing to digoxin toxicity have
been well documented and publicized, intoxication contin-
ues to be a major patient management problem. We pro-
posed that a computerized medical decision-making process
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could efficiently identify these factors in individual patients
and bring them to the attention of the attending physician.
We further postulated that this increased suspicion of di-
goxin toxicity would lead to an increase in the preventive
and therapeutic measures taken by physicians. A comput-
erized monitoring system was developed and implemented
at LDS Hospital, whereby patients were automatically mon-
itored for existing signs and predisposing factors of digoxin
intoxication.
Methods
HELP Computer System. To screen patients daily for
conditions that increase the likelihood of digoxin toxicity,
the medical decision-making system Health Evaluation
through Logical Processing (HELP) was used. The system
(Fig. 1) is described in detail elsewhere (8). Briefly, it
accesses patient data from a comprehensive patient data base
and applies these data to a set of decision criteria. These
criteria are established by medical experts and encoded into
a form (the HELP logic) interpretable by the system. The
HELP logic for a single decision is formated into a single
module that can be accessed, evaluated and modified in-
dependently from the data and other HELP logic modules.
Each logic module corresponds to a storable data code along
with its associated textual message. These messages can be
modified by the outcome of the HELP evaluation. For ex-
ample, laboratory values or text modifiers (such as mild,
moderate or severe) may be incorporated into the message.
A positive evaluation of a HELP logic module, then, con-
stitutes a medical decision. These decisions can be sent by
Figure 1. The HELP system.
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the HELP system to application programs or they can be
returned to the data base for future access by HELP and
data review programs, or both.
Digoxin alert system. Application of the HELP system
to the problem of digoxin toxicity was accomplished by the
establishment of a series of digoxin alert HELP logic mod-
ules. Each module was designed to alert the physician to a
condition that could be of concern in management of the
patient with digoxin. Table 1 lists the alert modules along
with their text and decision criteria. In evaluating these
modules, HELP utilizes serum chemistry data, arterial blood
gas data, electrocardiographic interpretations, medications
and demographic data. In addition, outcomes from previous
HELP evaluations of the alert modules are accessed to pre-
vent excessive repetition of alerts. Because these data are
all routinely stored in the computerized patient data records,
no additional data entry is required to evaluate the alert
modules.
To completely automate the process, a time-driven di-
goxin alert program was written. Each night, this program
activates the HELP evaluation of the alert modules for all
patients in the hospital. Alert messages returned from HELP
are formated into a "digoxin alert report" that is sent out
to a line printer in the nursing division nearest the patient
(Table 2). This report is placed in the patient chart by nursing
personnel.
Study design. After a trial period, a double-blind ran-
domized study was initiated to determine the effect of the
digoxin alerts on patient management. All patients receiving
digoxin were included in the study. A random number gen-
erator was used to assign patients to an alert or nonalert
group. For patients in the alert group, the decision process
and alert reporting were carried out as outlined. The digoxin
alert reports were withheld from the charts of patients in
the nonalert group. After 3 months of operation, a blinded
medical record review was carried out in accordance with
a protocol aimed at identifying physician actions with pos-
sible relation to the digoxin alerts. Progress notes and phy-
sicians' orders were reviewed for the day of each generated
alert. All data from the patient record review and the alert
data were entered into the patient data base for computer-
assisted analysis.
Data analysis. The HELP system was used to segregate
the main patient population into alert and nonalert groups.
These groups were then evaluated for differences in size,
gender and age distributions and medical versus surgical
service. Statistical analysis was performed with the chi-
square test.
The frequency of occurrence of each of the digoxin alerts
was established for both the alert and nonalert groups and
evaluated with the chi-square test. A proportion method
described by Armitage (9) was used in evaluating the dis-
tribution of physician actions recorded for the two groups.
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Alert Module Alert Text Decision Criteria
Low weight
Old age:
High serum digoxin level
Low Strum potassium level
Renal insufficiency
No serum potassium
Concurrent beta-
blocking agent
Concurrent quinidine
Concurrent calcium channel
blocking agent
Acid-base disorder
Hypoxemia
Atrial tachycardia with block
Junctional arrhythmia
Ventricular arrhythmia
Sinoatrial block
Atrioventricular block
Acute infarction
Low body weight of (* kg) may require
reduced digoxin dosage
Age of patient (* yr) may require reduced
digoxin dosage
Last serum digoxin level (* ng/ml) indicates
that digoxin therapy []
= must be closely monitored
= is currently contraindicated
Last serum K + (* mEq!l); suggest []
= that digoxin be withheld until corrected
= that serum K + be monitored
Last serum creatine (* mglI00 ml) suggest
renal impairment; the dose of digoxin may
need to be reduced
The serum potassium has not been done;
suggest that K + be monitored
Concurrent use of digoxin and beta-blocking
agents can result in bradycardia; suggest
monitoring ventricular rate
Concurrent use of digoxin and quinidine can
result in increased serum digoxin levels;
suggest monitoring serum digoxin level
Concurrent use of digoxin and calcium
channel blocking agents can induce
bradycardia; suggest monitoring
ventricular rate
Blood pH (*) out of normal limits; suggest
caution in use of digoxin
Blood POl (* mm Hg); suggest care in use
of digoxin
ECG finding of atrial tachycardia with block
suggests possible digoxin toxicity
ECG indicates []; use digoxin with caution
= junctional tachycardia
= junctional rhythm
Ventricular II present; suggest caution in use
of digoxin
= premature complexes
= tachycardia
ECG finding of second degree SA block;
consider modification of digoxin therapy
[] AV block suggests caution in use of digoxin
= first degree
= second degree
= complete
Acute infarction; consider reduction in
digoxin dosage
Digoxin dosage 2: 0.25 mg/day and (male
weight < 55 kg, female weight < 40 kg)
Digoxin dosage 2: 0.25 mg/day and
age 2: 75 years
Serum digoxin level > 2 ng/ml but < 3 ng/ml
Serum digoxin level > 2 ng/ml but < 3 ng/ml
Serum digoxin level 2: 3 ng/rnl
Serum potassium $ 3.0 mEqlliter
Serum potassium> 3.0 mEq/liter
but $ 3.6 mEq/liter
Serum creatine level 2: 1.6 mg/lOO ml
No serum potassium level found
Current beta-blocking prescription
Current quinidine prescription
Current calcium channel blocking
agent prescription
pH $ 7.3 or pH > 7.5
Arterial POl $ 60 mm Hg
ECG finding exists
ECG finding exists
ECG finding exists
ECG finding exists
ECG finding exists
ECG finding exists
ECG finding exists
ECG finding exists
ECG finding exists
ECG finding exists
AV = atrioventricular; ECG = electrocardiogram; POl = partial pressure or oxygen; * = value insertion point; [] = text modifier insertion point;
(=) = text modifier.
Results
Patient profile. Over a 3 month period, 396 patients
were monitored with the digoxin alert program. Of these
patients, 211 (53%) were randomized to the alert group
while 185 (47%) were randomized to the nonalert group.
The male:female ratio was 1:l , medical:surgical service ra-
tio was 0.8: 1 and the mean age was 69 years. There was
no statistically significant difference between the two groups
for these variables.
Distribution of alerts. The results of the alert distri-
bution are tabulated in Table 3. The number of patients in
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Table 2. Sample Digoxin Alert Report
Digoxin Alert Report-06/15/83 15:20
Patient: XXXXXXXXXXXX Number 4981213
Dr: XXXXXXXXXXXXXXX Room: 4W09
Digoxin dosage: 0.250 MG, TABS
ALERT 18: The serum potassium has not been done. Suggest that
serum K + be monitored.
ALERT 22: Concurrent use of digoxin and quinidine can result in
increased serum digoxin levels. Suggest monitoring serum digoxin
levels.
ALERT 39: First degree AV block, Suggest caution in use of digoxin,
each group receiving a given alert along with the corre-
sponding percent of the total number of patients in the group
are shown for each alert, Statistical data are for comparison
between the alert distributions in the alert and nonalertgroups,
Only for the low serum potassium alert did the analysis
show a statistically significant difference between these
groups,
Distribution of physician actions. Results from the
medical record review are listed in Table 4, The total number
of data entries (alert days) is given along with the frequency
of each action in the alert and nonalert groups, The "weighted
ratios" show the relative increase in frequency of action
taken between the two groups, These values are "weighted"
by the ratio of alert days, Statistically significant increases
in actions were found for the alert group in five areas: serum
digoxin determinations ordered, digoxin withheld beta-ad-
renergic blocking agent change, potassium supplement and
serum potassium determination ordered, Borderline statis-
Table 3. Distribution of Alerts
tical significance was obtained for increase in digoxin dos-
age reductions and notes of concern in progress notes for
the alert group, Overall, physician actions increased for the
alert group as evidenced by the statistically significant in-
crease in "any action taken",
Discussion
Theoretical considerations. Computer-assisted medi-
cal decision-making affords numerous advantages to the
clinician, In essence, this system adds another observer to
the patient care team, The computer system does not com-
pete with the clinician; rather, it supplements and backs up
the clinical observations, Human observers, of course, have
many advantages over computer systems, Human observers
are far better at synthesizing abstract concepts and calling
on previous experience, Additionally, many more data are
available to the human observer.
Computer decision-making is restricted to a predefined
logic format and set of data and, thus, is inflexible once
programmed. It does, however, have some advantages over
the human observer. The computer is ideal for monitoring
the multitude of small mundane details that so often escape
the attention, interest and memory of the human observer.
Therefore, the computer decision-making system serves as
an additional data input for the clinician and, in this way,
expands his or her medical decision-making capabilities. By
combining the human and computer capabilities, the strengths
of both can be used effectively to provide better patient
observation and care.
System performance. The digoxin alert system was re-
Any alert
Low weight
Old age
High serum digoxin level
Low serum potassium level
Renal insufficiency
No serum potassium
Concurrent beta-blocking agent
Concurrent quinidine
Concurrent calcium channel
blocking agent
Acid-base disorder
Hypoxemia
Atrial tachycardia with block
Junctional arrhythmia
Ventricular arrhythmia
Sinoatrial block
Atrioventricular block
Acute infarction
NS = not significant; S = significant.
Alerted
(no.l%)
150171
0/0
8/4
8/4
21110
1517
2/1
19/9
12/6
2/1
7/3
42/20
110.5
0/0
1517
1/0,5
6/3
3/1
Nonalerted Combined Statistical
(no.l%) (no.l%) Significance
134/72 284/72 NS
1/0.5 1/0,2 NS
12/6 20/5 NS
814 16/4 NS
34118 55114 S
915 24/6 NS
3/2 5/1 NS
16/9 35/9 NS
6/3 18/5 NS
1/0.5 3/1 NS
4/2 1113 NS
37120 79/20 NS
0/0 110,2 NS
2/1 2/0.4 NS
10/5 25/6 NS
9/0 110.2 NS
8/4 1414 NS
2/1 51 NS
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Table 4. Distribution of Physician Actions
Frequency Frequency Weighted
for Alert for Nonalert Ratio Statistical
Group Group AI/Nal P Value
----
Alert days 260 246
Serum digoxin determination ordered 48 17 2.67 < 0.0001 S
Digoxin withheld 27 9 2.84 < 0.002 S
Digoxin discontinued 5 2 2.37 < 0.14 NS
Digoxin dose reduced 5 I 4.73 < 0.06 NS
Quinidine changed 2 I 1.89 < 0.30 NS
Beta-bloc king agent changed 4 0 < 0.03 S
Potassium supplement ordered 69 48 1.33 < 0.04 S
Serum potassium determination ordered 117 89 1.24 < 0.02 S
Oxygen delivery increased 42 32 1.24 < 0.16 NS
Concern of toxicity in note 5 I 4.73 < 0.06 NS
Electrocardiogram ordered 36 29 1.17 < 0.25 NS
Any action taken 175 136 1.22 < 0.003 S
Al ,. alerted; Nal = nonalerted; NS = not statistically significant; S = statistically significant.
liable and consistent in its performance. Occasional errors
in the data base resulted in some erroneous decisions. Over-
all, highly verifiable decisions were generated. Failure of
the alert program to activate and complete evaluation of the
entire hospital population was also rare, occurring only two
or three times during the 3 month period. Once imple-
mented. the system was entirely automatic. No time was
expended by hospital personnel in data entry or program
activation.
Study design considerations. In the implementation of
the randomized double-blind study, the preliminary trials
of the digoxin alert process accustomed the medical staff to
the digoxin alert reports. As a result, they gained some
experience in evaluating the significance of the alerts before
the study began. The medical staff was not told that a study
was being performed. Because LDS Hospital is a teaching
hospital, the responses of medical students, interns, resi-
dents and attending physicians were measured by the study.
The HELP system is used extensively at LDS Hospital, and
numerous alerting systems are already a part of routine daily
patient care. Because the physicians had previous exposure
to similar alerting systems their response was more likely
to be based on the content of the alert messages rather than
the novelty of a computerized monitoring system.
Alert frequencies. The only apparent aberration from
randomness between the alert and nonalert groups was that
more patients in the nonalert group received the low serum
potassium alert. We can only speculate as to whether there
is any causal relation in this finding. Nonetheless, the fact
that more patients were hypokalemic in the nonalert group
would have the tendency to increase the number of actions
in this group. If any significant bias in the distribution of
physician actions resulted from this, the bias would be for
an increase in actions for the nonalert group.
The high frequency of alerts generated attests to the com-
plexity of managing patients with digoxin. In decreasing
order of frequency, the most common alerts were hypox-
emia, low serum potassium, concurrent use of a beta-ad-
renergic blocking agent, ventricular arrhythmia and renal
impairement. Because of varying degrees of incompleteness
in the data base, however, the true relative and absolute
frequencies of these alerts may vary significantly from those
reported. The frequencies given represent the minimal prev-
alence of each alert state in the study group.
Effects on patient management. An objective analysis
of the physician response to the digoxin alerts is accom-
plished with the distribution of possible alert-related actions
among the alert and nonalert groups. Although some of the
reported action distributions were not statistically signifi-
cant, in every case the alert group received more actions
than the nonalert group. There was a statistically significant
increase of "any related action" of 22% in the alert group.
These increases indicate that the physicians received in-
formation from the alerts that altered their management of
the patient receiving digoxin. One may ask whether this
increase in action constitutes a benefit or only an added
expense to the patient. Objective measurement of actual
patient benefit will require study of a more extensive patient
population. The cost of digoxin intoxication in terms of
lives and money is impressive. Experts in the field have
published guidelines and suggested certain actions for phy-
sicians when the alert states monitored by this system are
encountered in patients receiving digoxin (2,3,7). We found
that the digoxin alert system made physician behavior more
consonant with these suggested protocols. We anticipate that
ultimately the patient will benefit directly by having a de-
creased morbidity and mortality as a result of an increased
physician awareness of potential digoxin intoxication.
Conclusion. The clinical response to the digoxin alert
system indicates that the system was successful in increasing
physician awareness of conditions predisposing their pa-
tients to digoxin intoxication. This computer-assisted med-
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ical decision-making system adds another observer to the
clinical team and enhances the decision-making capabilities
of the physician. Future refining of the decision logic and
expansion of the data base will further extend the utility of
this valuable tool.
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